The Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance
The Government of Canada and the Bill & Melinda Gates Foundation have supported the establishment of the CHVI Research and Development Alliance, which is part of the Renewed CHVI. The Alliance network in Canada is bringing together leading researchers from the public and private sectors, as well as the international community, to develop innovative solutions to the challenges facing HIV vaccine development.
At the heart of the CHVI Research and Development Alliance is the Alliance Coordinating Office (ACO). The ACO will focus on building and sustaining the Alliance, advising the Government of Canada and the Bill & Melinda Gates Foundation on research gaps, prospecting for innovative proposals to respond to identified gaps, and promoting synergy among Alliance members.
An Advisory Board will provide governance and oversight to the Alliance and other HIV prevention activities. The role of the Advisory Board is to provide recommendations on projects to be funded to CHVI Ministers and the Bill & Melinda Gates Foundation and to oversee the implementation of the Alliance.
The Alliance will:
- engage vaccine researchers, private industry, social scientists and international organizations to work towards common HIV vaccine research and development goals;
- help move research from the lab to internationally-recognized clinical trials;
- help low- and middle-income countries build regulatory capacity to ensure clinical trials adhere to appropriate scientific and ethical standards;
- improve knowledge exchange to enhance collaboration and advance vaccine research and development; and
- support technologies created by small and medium sized Canadian companies to advance the development of HIV vaccines.